Heart Failure in Sub-Saharan Africa

Joseph Gallagher, Kenneth McDonald, Mark Ledwidge, Chris Watson

Research output: Contribution to journalReview article

Abstract

Heart failure is a growing problem in sub-Saharan Africa. This arises as the prevalence of risk factors for cardiovascular disease rises, life expectancy increases and causes of heart failure more common in Africa, such as rheumatic heart disease and endomyocardial fibrosis, continue to be a significant issue. Lack of access to diagnostics is an issue with the expense and technical expertise required for echocardiography limiting access. Biomarker strategies may play a role here. Access to essential medicines is also limited and requires a renewed focus by the international community to ensure that appropriate medications are readily available, similar to that which has been implemented for HIV and malaria.

Original languageEnglish
Pages (from-to)21-24
Number of pages4
JournalCardiac Failure Review
Volume4
Issue number1
DOIs
Publication statusPublished - 01 May 2018

Fingerprint

Africa South of the Sahara
Heart Failure
Endomyocardial Fibrosis
Professional Competence
Rheumatic Heart Disease
Life Expectancy
Malaria
Echocardiography
Cardiovascular Diseases
Biomarkers
HIV

Cite this

Gallagher, Joseph ; McDonald, Kenneth ; Ledwidge, Mark ; Watson, Chris . / Heart Failure in Sub-Saharan Africa. In: Cardiac Failure Review. 2018 ; Vol. 4, No. 1. pp. 21-24.
@article{7570518af6f64c548f94b604df6f4f64,
title = "Heart Failure in Sub-Saharan Africa",
abstract = "Heart failure is a growing problem in sub-Saharan Africa. This arises as the prevalence of risk factors for cardiovascular disease rises, life expectancy increases and causes of heart failure more common in Africa, such as rheumatic heart disease and endomyocardial fibrosis, continue to be a significant issue. Lack of access to diagnostics is an issue with the expense and technical expertise required for echocardiography limiting access. Biomarker strategies may play a role here. Access to essential medicines is also limited and requires a renewed focus by the international community to ensure that appropriate medications are readily available, similar to that which has been implemented for HIV and malaria.",
author = "Joseph Gallagher and Kenneth McDonald and Mark Ledwidge and Chris Watson",
year = "2018",
month = "5",
day = "1",
doi = "10.15420/cfr.2018:4:1",
language = "English",
volume = "4",
pages = "21--24",
journal = "Cardiac Failure Review",
issn = "2057-7540",
number = "1",

}

Gallagher, J, McDonald, K, Ledwidge, M & Watson, C 2018, 'Heart Failure in Sub-Saharan Africa', Cardiac Failure Review, vol. 4, no. 1, pp. 21-24. https://doi.org/10.15420/cfr.2018:4:1

Heart Failure in Sub-Saharan Africa. / Gallagher, Joseph; McDonald, Kenneth; Ledwidge, Mark; Watson, Chris .

In: Cardiac Failure Review, Vol. 4, No. 1, 01.05.2018, p. 21-24.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Heart Failure in Sub-Saharan Africa

AU - Gallagher, Joseph

AU - McDonald, Kenneth

AU - Ledwidge, Mark

AU - Watson, Chris

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Heart failure is a growing problem in sub-Saharan Africa. This arises as the prevalence of risk factors for cardiovascular disease rises, life expectancy increases and causes of heart failure more common in Africa, such as rheumatic heart disease and endomyocardial fibrosis, continue to be a significant issue. Lack of access to diagnostics is an issue with the expense and technical expertise required for echocardiography limiting access. Biomarker strategies may play a role here. Access to essential medicines is also limited and requires a renewed focus by the international community to ensure that appropriate medications are readily available, similar to that which has been implemented for HIV and malaria.

AB - Heart failure is a growing problem in sub-Saharan Africa. This arises as the prevalence of risk factors for cardiovascular disease rises, life expectancy increases and causes of heart failure more common in Africa, such as rheumatic heart disease and endomyocardial fibrosis, continue to be a significant issue. Lack of access to diagnostics is an issue with the expense and technical expertise required for echocardiography limiting access. Biomarker strategies may play a role here. Access to essential medicines is also limited and requires a renewed focus by the international community to ensure that appropriate medications are readily available, similar to that which has been implemented for HIV and malaria.

U2 - 10.15420/cfr.2018:4:1

DO - 10.15420/cfr.2018:4:1

M3 - Review article

C2 - 29892471

VL - 4

SP - 21

EP - 24

JO - Cardiac Failure Review

JF - Cardiac Failure Review

SN - 2057-7540

IS - 1

ER -